Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2815

Lack of any Impact of Histopathology Type on Prognosis in Patients with Early-Stage Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix  

Teke, Fatma (Department of Radiation Oncology, Faculty of Medicine, Dicle University)
Yoney, Adnan (Department of Radiation Oncology, Faculty of Medicine, Karadeniz Technical University)
Teke, Memik (Department of Radiology, Faculty of Medicine, Dicle University)
Inal, Ali (Department of Medical Oncology, Faculty of Medicine, Dicle University)
Urakci, Zuhat (Department of Medical Oncology, Faculty of Medicine, Dicle University)
Eren, Bekir (Okmeydani Training and Research Hospital)
Zincircioglu, Seyit Burhanedtin (Department of Radiation Oncology, Faculty of Medicine, Dicle University)
Buyukpolat, Muhammed Yakup (Okmeydani Training and Research Hospital)
Ozer, Ali (Department of Obstetrics and Gynecology, Faculty of Medicine, Dicle University)
Isikdogan, Abdurrahman (Department of Medical Oncology, Faculty of Medicine, Dicle University)
Unsal, Mustafa (Okmeydani Training and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2815-2819 More about this Journal
Abstract
Background: The aim of this study was to evaluate the prognosis of patients with stage IA-IIB cervical carcinoma and to investigate a possible correlation of histology with prognosis. Materials and Methods: Two hundred fifty one patients with adenocarcinoma and squamous cell carcinoma (SCC) histology for FIGO (International Federation of Gynecology and Obstetrics) stage IA-IIB uterine cervical carcinomas at the Radiation Oncology Clinic of GH Okmeydan Training and Research Hospital between January 1996 and December 2006 were selected, analyzed retrospectively and evaluated in terms of general characteristics and survival. Disease-free survival (DFS) and overall survival (OS) was calculated using the Kaplan-Meier method and differences were compared with the log-rank test. Multivariate analysis using a Cox-proportional hazards model was used to adjust for prognostic factors and to estimate hazard ratio (HR) with 95% confidence interval (CI). Results: There was no differences between the two tumour types in age, stage, pelvic nodal metastasis, parametrial invasion, surgical margin status, DSI, LVSI, maximal tumor diameter, grade, and treatment modalities. 5-year OS and DFS were 73% and 77%, versus 64% and 69%, for SCC and adenocarcinoma, respectively (p> 0.05). Multivariate analysis revealed independent prognostic factors including pelvic nodal metastasis and resection margin status for OS (p=0.008, p=0.002, respectively). Conclusions: Prognosis of FIGO stage IA-IIB cervical cancer patients was found to be the same for those with adenocarcinoma and SCC.
Keywords
Adenocarcinoma; squamous cell carcinoma; uterine cervical carcinoma; histology; prognosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Vizcaino AP, Moreno V, Bosch FX, et al (1998). International trends in the incidence of cervical cancer: I. adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer, 75, 536-45.   DOI
2 Smith HO, Tiffany MF, Qualls CR and Key CR. (2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-A 24-year population-based study. Gynecol Oncol, 78, 97-105.   DOI   ScienceOn
3 Trattner M, Graf AH, Lax S, et al (2001). Prognostic factors in surgically treated stage Ib-IIb cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol, 82, 11-6.   DOI   ScienceOn
4 Visioli CB, Zappa M, Ciatto S, Iossa A, Crocetti E (2004). Increasing trends of cervical adenocarcinoma incidence in central Italy despite extensive screening programme, 1985- 2000. Cancer Detect Prev, 28, 461-4.   DOI   ScienceOn
5 Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S (2004). Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer, 100, 1035-44.   DOI   ScienceOn
6 Xie XZ, Song K, Cui B, et al (2012). Clinical and pathological factors related to the prognosis of Chinese patients with stage Ib to IIb cervical cancer. Asian Pac J Cancer Prev, 13, 5505-10.   DOI   ScienceOn
7 Look KY, Brunetto VL, Clarke-Pearson DL, et al (1996). An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol, 63, 304-11.   DOI   ScienceOn
8 Lee KB, Lee JM, Park CY, et al (2006). What is the difference between squamous cell carcinoma and adenocarcinoma of the cervix? a matched case-control study. Int J Gynecol Cancer, 16, 1569-73.   DOI   ScienceOn
9 Lee YY, Choi CH, Kim TJ, et al (2011). A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. Gynecol Oncol, 120, 439-43.   DOI   ScienceOn
10 Liu S, Semenciw R, Mao Y (2001). Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ, 164, 1151-2.
11 Monk BJ, Tewari KS, Koh WJ (2007). Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions. J Clin Oncol, 25, 2952-65.   DOI   ScienceOn
12 Nakanishi T, Ishikawa H, Suzuki Y, et al (2000). A comparison of prognoses of pathologic stage IB adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol Oncol, 79, 289-93.   DOI   ScienceOn
13 Peters RK, Chao A, Mack TM, et al (1986). Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst, 76, 423-8.
14 Sherman ME, Wang SS, Carreon J, Devesa SS (2005). Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer, 103, 1258-64.   DOI   ScienceOn
15 Hopkins MP, Morley GW (1991). A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstetrics Gynecol, 77, 912-7.
16 Shingleton HM, Bell MC, Fremgen A, et al (1995). Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer, 76, 1948-55.   DOI
17 Intaraphet S, Kasatpibal N, Siriaunkgul S, et al (2013). Prognostic impact of histology in patients with cervical squamous cell carcinoma, adenocarcinoma and small cell neuroendocrine carcinoma. Asian Pac J Cancer Prev, 14, 5355-60.   DOI   ScienceOn
18 Gien LT, Beauchemin MC, Thomas G (2010). Adenocarcinoma: a unique cervical cancer. Gynecol Oncol, 116, 140-6.   DOI   ScienceOn
19 Huang YT, Wang CC, Tsai CS, et al (2012). Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys, 84, 420-7.   DOI   ScienceOn
20 Irie T, Kigawa J, Minagawa Y, et al (2000). Prognosis and clinicopathological characteristics of ib-iib adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol, 26, 464-7.   DOI   ScienceOn
21 Kasamatsu T, Onda T, Sawada M, Kato T, Ikeda S (2009). Radical hysterectomy for figo stage iib cervical cancer: clinicopathological characteristics and prognostic evaluation. Gynecol Oncol, 114, 69-74.   DOI   ScienceOn
22 Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S (2012). Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol, 125, 292-6.   DOI   ScienceOn
23 Ayhan A1, Al RA, Baykal C, et al (2004). A comparison of prognoses of figo stage ib adenocarcinoma and squamous cell carcinoma. Int J Gynecol Cancer, 14, 279-85.   DOI   ScienceOn
24 Kleine W, Rau K, Schwoeorer D, Pfleiderer A (1989). Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol, 35, 145-9.   DOI   ScienceOn
25 Landoni F, Maneo A, Colombo A, et al (1997). Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet, 350, 535-40.   DOI   ScienceOn
26 Aoki Y, Sasaki M, Watanabe M, et al (2000). High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation. Gynecologic Oncology, 77, 305-09.   DOI   ScienceOn
27 Baalbergen A, Veenstra Y, Stalpers L (2013). Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix. Cochrane Database Syst Rev, 1, 6248.
28 Chen YL, Ho CM, Chen CA, et al (2011). Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma. Int J Gynaecol Obstet, 112, 135-9.   DOI   ScienceOn
29 Eifel PJ, Burke TW, Morris M, Smith TL (1995). Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol, 59, 38-44.   DOI   ScienceOn
30 Eifel PJ, Morris M, Oswald MJ, Wharton JT, Delclos L (1990). Adenocarcinoma of the uterine cervix. prognosis and patterns of failure in 367 cases. Cancer, 65, 2507-14.   DOI
31 Fregnani JH, Soares FA, Novik PR, Lopes A, Latorre MR (2008). Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol, 136, 215-23.   DOI   ScienceOn